Type 2 Diabetes Linked to 53% Higher Risk of Alzheimer’s Disease
- New research published in Alzheimer’s Research & Therapy quantifies the annual incidence of Alzheimer’s disease in individuals with type 2 diabetes at 4.7 cases per 1,000 person-years.
- The systematic review and meta-analysis analyzed 40 studies encompassing over 27 million data points to determine that type 2 diabetes increases the adjusted relative risk of Alzheimer’s by 53 percent.
- Study authors emphasize that combining incidence rates with relative risk measures provides a clearer picture of cognitive disease burden, supporting the integration of cognitive risk prevention into routine diabetes care.
Type 2 diabetes significantly increases the risk of developing Alzheimer’s disease, according to a systematic review and meta-analysis published in Alzheimer’s Research & Therapy. Researchers evaluated 40 studies to determine both how often new cases occur and how the risk compares to individuals without the condition.
The analysis revealed that if 1,000 people living with type 2 diabetes are followed for a year, an estimated average of 4.7 would develop Alzheimer’s. The pooled incidence of Alzheimer’s disease among individuals with type 2 diabetes sat at 4.71 cases per 1,000 person-years, based on data gathered through April 2026 across databases including MEDLINE, CINAHL via EBSCO, Embase via Ovid, and Scopus.
Synthesizing 27 Million Data Points
Earlier epidemiological evidence linked type 2 diabetes to an elevated risk of dementia, but prior syntheses frequently combined heterogeneous definitions of diabetes and dementia without comprehensively quantifying specific Alzheimer’s incidence. To resolve these inconsistencies, investigators selected 40 studies out of an initial 9,431 records retrieved during their comprehensive literature search.
Together, the included studies encompassed an unadjusted sum of 27,102,559 data points. Out of this collection of research, disease incidence data was supplied by 23 studies, whereas 26 studies detailed adjusted relative risks. By applying random-effects models, the researchers determined that type 2 diabetes carried an adjusted relative risk of 1.53 for Alzheimer’s disease, representing a risk elevated by 53 percent compared to individuals without type 2 diabetes.
“Relative risk tells us how two groups compare, while incidence tells us how often new cases occur: putting those numbers together gives us a clearer picture of the burden of Alzheimer’s disease among people living with type 2 diabetes,” said Dr Emmanuel Adewuyi, an NHMRC Investigator Fellow at the Curtin School of Population Health.
Variation Across Ascertainment Methods
The study authors found notable variation among the papers, which was demonstrated by a broad 95 percent prediction interval spanning from 0.76 to 29.30 per 1,000 person-years. Ascertainment methodology accounted for noticeable variation in the findings. A pooled incidence of 4.00 per 1,000 person-years came from studies utilizing administrative ascertainment, whereas research depending on non-administrative ascertainment reported an incidence of 10.24 per 1,000 person-years.
Incidence rates were observed to be numerically greater in women than in men through sex-stratified analyses, recording 3.62 against 2.76 per 1,000 person-years. However, the adjusted relative risks remained very similar between sexes, sitting at 1.73 for women and 1.76 for men. Subgroup analyses remained consistent across categories, and sensitivity testing confirmed the findings.
“While many earlier reviews combined different types of diabetes or dementia, this review focused specifically on type 2 diabetes and Alzheimer’s disease and estimated how often new cases occurred,” Adewuyi said.
Disclaimer: The information provided in this article is for educational and scientific communication purposes only and does not constitute medical advice.